Why Choose Smartbrain.io for Pharmaceutical Oracle Asset Management
67% of life sciences companies struggle with FDA compliance during Pharmaceutical Oracle Asset Management upgrades, causing project delays of 3+ months. Smartbrain.io eliminates these bottlenecks by aligning Oracle Enterprise Asset Management (eAM) with strict GxP and 21 CFR Part 11 requirements.
Proven methodology — Our discovery phase and architecture review map your calibration and maintenance workflows directly into Oracle Cloud SCM. Using Agile 2-week sprints, we ensure average go-live timelines of just 8–16 weeks.
Certified Oracle expertise — Every engagement is led by a dedicated Solution Architect, a Project Manager, and certified Oracle Cloud Infrastructure developers. Our team has executed over 85+ enterprise projects, specializing in complex pharmaceutical manufacturing environments.
Risk mitigation — We offer a fixed-price delivery model with 3–12 months of hypercare included. Our strict data validation and rollback planning result in zero-downtime go-lives for 92% of our asset management deployments.
Proven methodology — Our discovery phase and architecture review map your calibration and maintenance workflows directly into Oracle Cloud SCM. Using Agile 2-week sprints, we ensure average go-live timelines of just 8–16 weeks.
Certified Oracle expertise — Every engagement is led by a dedicated Solution Architect, a Project Manager, and certified Oracle Cloud Infrastructure developers. Our team has executed over 85+ enterprise projects, specializing in complex pharmaceutical manufacturing environments.
Risk mitigation — We offer a fixed-price delivery model with 3–12 months of hypercare included. Our strict data validation and rollback planning result in zero-downtime go-lives for 92% of our asset management deployments.












